Access to the life science market can be a headache for multinational pharma and medical device companies, let alone small-medium sized enterprises (SMEs). SMEs can face significant challenges to introduce new and innovative products into the health and social care market.
The Innovation Nexus provides a single point of access for SMEs in the life science sector to a network of specialist support within Greater Manchester.
The Innovation Nexus is a gateway to a holistic business growth support offering, focused on the specialist needs of life science SMEs, delivered through a coherent support strategy and an all-inclusive approach to helping businesses develop their growth strategies.
The aim of the Innovation Nexus is to deliver long-term health and wealth benefits to Greater Manchester through investment, innovation, education and business growth, ultimately improving the health and wellbeing of the Greater Manchester population (and beyond).
INDUSTRY PARTNERSHIP WILL BE A KEY COMPONENT OF HOW HEALTH SYSTEMS WILL IMPROVE HEALTH OUTCOMES FOR THE POPULATIONS THEY SERVE
The challenge for healthcare businesses
Companies, especially SMEs, can face significant challenges to introduce their new and innovative products into the NHS. The complexity of public procurement, patient safety and a risk averse culture across multiple organisations can be daunting. The Innovation Nexus aims to provide a single source of resource that can help companies, particularly SMEs, understand the steps that need to be taken to support their business planning and engage with the NHS more easily, thus progressing the adoption of their innovation at pace and with fewer unanticipated obstacles.
How can the Innovation Nexus help?
Help with navigating NHS procurement
Information about funding and investment
Help with setting up a trial of your innovation
Information on science parks and office locations in the GM AHSN footprint
Connections to organisations that can help you progress your innovation
Speak directly to a GM AHSN advisor with NHS expertise
Supporting a digital solution to diabetes foot health
Entec’s Silhouette® product enables rapid escalation and de-escalation of patients with diabetic foot ulcers to and from secondary care, and increases accuracy and objectivity of assessments through use of 3D wound imaging technology. This will reduce the number of follow-up appointments taking place in hospitals, by enabling remote review of patients’ wounds in their community.
Following a market research and engagement programme commissioned by Entec Health in the GM region during June to Sept 2014, Entec were supported with funding from GM through the now renamed Momentum funding scheme The GM funding support looks to enable joint-development of smarter business processes so that a way to initiate fast-track investment decisions for the Silhouette innovation can be developed, by NHS Trusts within the GM region.
Our colleagues at East Midlands AHSN are also supporting this innovation, working with Derby Teaching Hospitals NHS Foundation Trust, Derbyshire Community Healthcare Services NHS Foundation Trust, Entec Health Ltd and Aranz Medical Ltd to implement the Silhouette® 3D wound imaging system as part of an integrated pathway across both primary and secondary care. EMAHSN assisted with the procurement of the system and worked with all partners to get the new pathway implemented in four settings following an Innovation Exchange event.
Find out more about Entec Health Ltd.
Information and guidance
Access information and guidance on a range of topics related to working with and selling to the NHS, and find clear signposts to organisations that can help you achieve your goals.